一例难治性缺血性心肌病合并耐药菌感染的急诊左心室辅助植入术
Emergency Left Ventricular AssistImplantation for a Refractory Ischemic Cardiomyopathy with Drug-Resistant Bacterial Infection
摘要: 本病例展示了在严重心功能不全和复杂感染背景下,LVAD植入术的应用优势。尽管当前指南将严重感染视为LVAD植入的绝对禁忌证,但本案例的成功经验可能为未来严重缺血性心肌病患者的治疗提供有益参考。
Abstract: This case highlights the benefits of LVAD implantation in severe cardiac insufficiency and complex infections. While current guidelines classify serious infections as an absolute contraindication for LVAD implantation, the success of this case may offer valuable insights for future management of severe ischemic cardiomyopathy patients.
文章引用:刘锐奇, 陈胜. 一例难治性缺血性心肌病合并耐药菌感染的急诊左心室辅助植入术[J]. 临床医学进展, 2025, 15(5): 133-138. https://doi.org/10.12677/acm.2025.1551351

参考文献

[1] Tao, J., Sang, D., Zhen, L., Zhang, X., Li, Y., Wang, G., et al. (2023) Elevated Urine Albumin-to-Creatinine Ratio Increases the Risk of New-Onset Heart Failure in Patients with Type 2 Diabetes. Cardiovascular Diabetology, 22, Article No. 70. [Google Scholar] [CrossRef] [PubMed]
[2] Seguchi, O., Kuroda, K., Kumai, Y., Nakajima, S., Yanase, M., Wada, K., et al. (2018) Clinical Outcomes of Patients with the Heartmate II Left Ventricular Assist Device: A Single-Center Experience from Japan. Transplantation Proceedings, 50, 2726-2732. [Google Scholar] [CrossRef] [PubMed]
[3] ten Hove, D., Treglia, G., Slart, R.H.J.A., Damman, K., Wouthuyzen-Bakker, M., Postma, D.F., et al. (2020) The Value of 18F-FDG PET/CT for the Diagnosis of Device-Related Infections in Patients with a Left Ventricular Assist Device: A Systematic Review and Meta-analysis. European Journal of Nuclear Medicine and Molecular Imaging, 48, 241-253. [Google Scholar] [CrossRef] [PubMed]
[4] 卿平, 杜娟, 周星彤, 等. 中国左心室辅助装置候选者术前评估与管理专家共识(2023年) [J]. 中国循环杂志, 2023, 38(8): 799-814.
[5] Tacconelli, E., Carrara, E., Savoldi, A., Harbarth, S., Mendelson, M., Monnet, D.L., et al. (2018) Discovery, Research, and Development of New Antibiotics: The WHO Priority List of Antibiotic-Resistant Bacteria and Tuberculosis. The Lancet Infectious Diseases, 18, 318-327. [Google Scholar] [CrossRef] [PubMed]
[6] Bittl, J.A., Baber, U., Bradley, S.M. and Wijeysundera, D.N. (2016) Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients with Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 134, e156-e178. [Google Scholar] [CrossRef] [PubMed]
[7] Haffner, S.M., Lehto, S., Rönnemaa, T., Pyörälä, K. and Laakso, M. (1998) Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction. New England Journal of Medicine, 339, 229-234. [Google Scholar] [CrossRef] [PubMed]
[8] Ye, Z., Su, Q. and Li, L. (2017) The Clinical Effect of Nicorandil on Perioperative Myocardial Protection in Patients Undergoing Elective PCI: A Systematic Review and Meta-analysis. Scientific Reports, 7, Article No. 45117. [Google Scholar] [CrossRef] [PubMed]